ALKS
USDAlkermes plc Ordinary Shares
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$30.000
Máximo
$30.630
Mínimo
$29.770
Volumen
0.42M
Fundamentos de la Empresa
Capitalización de Mercado
5.0B
Industria
Drug Manufacturers - Specialty & Generic
País
Ireland
Estadísticas de Negociación
Volumen Promedio
2.00M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Wells Fargo Maintains Overweight on Alkermes, Lowers Price Target to $42
Wells Fargo analyst Benjamin Burnett maintains Alkermes with a Overweight and lowers the price target from $44 to $42.
Needham Maintains Buy on Alkermes, Raises Price Target to $44
Needham analyst Ami Fadia maintains Alkermes with a Buy and raises the price target from $43 to $44.
Alkermes plc Reports Third Quarter 2025 Financial Results
Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving ...
Mizuho Maintains Outperform on Alkermes, Raises Price Target to $45
Mizuho analyst Uy Ear maintains Alkermes with a Outperform and raises the price target from $40 to $45.
Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $45
Piper Sandler analyst David Amsellem reiterates Alkermes with a Overweight and raises the price target from $38 to $45.
RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $47
RBC Capital analyst Leonid Timashev maintains Alkermes with a Outperform and raises the price target from $45 to $47.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.